Category: Europe

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens

Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB) complex, remains one of the leading infectious causes of death worldwide, with an estimated 1.6 million TB deaths in 2021 (World Health Organization, 2022). Rapid and accurate TB diagnosis is critical to ensure timely initiation of anti-TB therapy (Walzl et al., 2018)….

Continue Reading Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens

Establishment and evaluation of a nomogram for predicting the survival outcomes of patients with diffuse large B-cell lymphoma based on International Prognostic Index scores and clinical indicators – Chen

Highlight box Key findings • A nomogram for predicting survival outcomes in patients with diffuse large B-cell lymphoma based on IPI score and clinical indicators was established. What is known and what is new? • Current prognostic models do not work well. Although there are prognostic models based on genetic…

Continue Reading Establishment and evaluation of a nomogram for predicting the survival outcomes of patients with diffuse large B-cell lymphoma based on International Prognostic Index scores and clinical indicators – Chen

Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated) Video

0 views | February 1, 2023 Oncotarget published this research paper in Volume 14, entitled, “Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)” by the researchers from the Division of Hematology and Oncology, Northwestern University Feinberg School of…

Continue Reading Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated) Video

Whole Genome Sequencing Market Size [2023-2028]|Country Wise

Report Overview: Whole genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, including all of its genes and other DNA elements. It provides a comprehensive view of an organism’s genetic makeup, which can be used for a variety of purposes, such as disease diagnosis…

Continue Reading Whole Genome Sequencing Market Size [2023-2028]|Country Wise

Identification of key genes related to immune infiltration in cirrhosis via bioinformatics analysis

Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2012). Google Scholar  Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D. C. & Roudot-Thoraval, F….

Continue Reading Identification of key genes related to immune infiltration in cirrhosis via bioinformatics analysis

Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial | Oncology | JAMA Surgery

Key Points Question  What is the effect of focal vs extended irreversible electroporation (IRE) on early oncological control for patients with localized low- or intermediate-risk prostate cancer? Findings  In this randomized clinical trial with 106 patients, there was no significant difference in presence of clinically significant prostate cancer between the…

Continue Reading Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial | Oncology | JAMA Surgery

Oncotarget | Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)

“The current analysis provides updated results for these lymphoma patients with extended follow-up.”  Listen to an audio version of this press release BUFFALO, NY- February 1, 2023 – A new research paper was published in Oncotarget’s Volume 14 on January 26, 2023, entitled, “Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in…

Continue Reading Oncotarget | Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)

Bringing back the Dodo: Scientists work towards resurrecting extinct bird

If extinction ever had a poster child, it would be the Dodo. The flightless and perhaps feckless bird lived on the island of Mauritius till it was driven to extinction by Portuguese sailors who hunted it and introduced several predators. But now, scientists plan to use cutting-edge technology like DNA…

Continue Reading Bringing back the Dodo: Scientists work towards resurrecting extinct bird

Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Sherlock Biosciences has bought global molecular diagnostics company Sense Biodetection based out of Cambridge, U.K., to help it reach its goal of making diagnostics easy to use, cheap, disposable, and good for the environment. Sherlock’s purchase of Sense—which launched its fully integrated molecular diagnostic test that provides laboratory-quality results in…

Continue Reading Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Years that define eras | The Global Observer | Opinion

Just mentioning certain years in history like 1789 (the French Revolution), 1945 (the end of World War II) or 1989 (the fall of the Berlin Wall) is enough to bring to mind profound transformations. So it’s worth asking, what will we eventually look back on as the first iconic year…

Continue Reading Years that define eras | The Global Observer | Opinion

Fungi On Rise In US In Trend Believed To Be Linked To Warmer Temperatures – Reports

WASHINGTON (UrduPoint News / Sputnik – 02nd February, 2023) Cases of rare fungal infections are on the rise in the United States in a trend that scientists think is linked to warmer temperatures, The Wall Street Journal reported on Wednesday. “As fungi are exposed to more consistent elevated temperatures, there’s…

Continue Reading Fungi On Rise In US In Trend Believed To Be Linked To Warmer Temperatures – Reports

Alternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma – Consumer Health News

WEDNESDAY, Feb. 1, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma after induction treatment and autologous stem cell transplantation, maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be better than lenalidomide alone, according to a study published online Jan. 12 in The Lancet Oncology. Dominik Dytfeld, M.D.,…

Continue Reading Alternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma – Consumer Health News

Scientists reckon they will be able to bring the woolly mammoth back from extinction in four years

Scientists reckon they will be able to bring the woolly mammoth back from extinction in four years. (Image Credit: (colossal.com/mammoth/) The woolly mammoth (Mammuthus primigenius) was a legendary species of mammoth that went extinct roughly 10,000 years ago. They were one of the last in a line of mammoth species,…

Continue Reading Scientists reckon they will be able to bring the woolly mammoth back from extinction in four years

From Research to Real-World Applications

PRESS RELEASE Published February 2, 2023 The pet food packaging market is projected to reach value of USD 13.27 Billion by 2027, according to a current analysis by Emergen Research. This growth of the market for pet food packaging can be attributed to high rate of pet adoption and growing trend of…

Continue Reading From Research to Real-World Applications

Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial

Background Several randomised, phase 3 trials have investigated the value of different techniques of accelerated partial breast irradiation (APBI) for patients with early breast cancer after breast-conserving surgery compared with whole-breast irradiation. In a phase 3 randomised trial, we evaluated whether APBI using multicatheter brachytherapy is non-inferior compared with whole-breast…

Continue Reading Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial

CircRNA Circ_0000118 Regulates Malignancy of Cervical Cancer Cells by Regulating miR-211-5p/miR-377-3p/AKT2 Axis

Samples and Cell Lines A total of 78 pairs of tumor samples and the adjacent non-carcinoma control samples were collected by surgery from CC patients in our study. The peripheral blood was also sampled from each individual and the serum was prepared and preserved under − 80 °C till further analysis. The Medical…

Continue Reading CircRNA Circ_0000118 Regulates Malignancy of Cervical Cancer Cells by Regulating miR-211-5p/miR-377-3p/AKT2 Axis

AlphaFill: An AI Algorithm to Fill Missing Ligands and Cofactors in AlphaFold Models

According to Levinthal’s paradox, each protein may adopt around 10300 distinct structures. We now know 3-D structures for about 98% of the human proteome thanks to DeepMind’s AI system, AlphaFold. However, AlphaFold has limitations, such as its inability to generate coordinates for tiny molecules and ligands that are critical to…

Continue Reading AlphaFill: An AI Algorithm to Fill Missing Ligands and Cofactors in AlphaFold Models

Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology – University of Copenhagen – job portal

Job Portal Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences University of Copenhagen We are looking for a highly motivated and dynamic postdoc for an ambitious bioinformatician / data scientist for a two-year Postdoc with possibilities for extension commencing 1 May…

Continue Reading Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology – University of Copenhagen – job portal

Autochthonous Onchocerca lupi infection of a domestic dog in Austria | Parasites & Vectors

Grácio AJS, Richter J, Komnenou AT, Grácio MA. Onchocerciasis caused by Onchocerca lupi: an emerging zoonotic infection. Systematic review Parasitol Res. 2015;114:2401–13. doi.org/10.1007/s00436-015-4535-7 Article  Google Scholar  Bergua A, Hohberger B, Held J, Muntau B, Tannich E, Tappe D. Human case of Onchocerca lupi infection, Germany, August 2014. Euro Surveill. 2015;20:21099….

Continue Reading Autochthonous Onchocerca lupi infection of a domestic dog in Austria | Parasites & Vectors

Plasmatic circRNA Predicting the Occurrence of Human Glioblastoma

Introduction Gliomas are defined as human malignant tumors derived from glial cells. Gliomas account for almost 80% of all malignant brain tumors.1 To date, gliomas have beendivided into four subgroups from I to IV according to the pathologic grading system.2 The prognosis was associated with the subgroup. For the gliomas, lower…

Continue Reading Plasmatic circRNA Predicting the Occurrence of Human Glioblastoma

Leveraging 16S rRNA data to uncover vaginal microbial signatures in women with cervical cancer

1 Introduction Cervical cancer (CC) remains the fourth most common cancer in women worldwide, with 604,127 new cases in 2020 and more than 341,831 deaths, accounting for nearly 8% of all female cancer-related deaths annually (Sung et al., 2021). This common infection-related neoplasm and its premalignant precursor are caused by high-risk…

Continue Reading Leveraging 16S rRNA data to uncover vaginal microbial signatures in women with cervical cancer

Ultrasonic Diagnostic Equipment Market Size And Forecast -Samsung Medison, Philips, Konica Minolta, Hitachi Medical Systems, FUJIFILM SonoSite, Canon Medical Systems, Boston Scientific, BenQ Medical Technology, Alpinion Medical Systems, Abbott Mr Accuracy Reports announces the release of the report ‘ Ultrasonic Diagnostic Equipment Market Research Report by Category, form, Product, Type, End-User, Region – Global Forecast to 2027. The primary drivers of this growth are the increasing need for market information and sustainability of key trends.’ The internet industry report further includes market shortcomings, stability, growth drivers, restraining factors, opportunities over the forecast period. Our market research report forecasts in depth comprehensive analysis of the global market, presenting you with the newest insights of our leading analysts.Get an Exclusive Sample of Report on the Ultrasonic Diagnostic Equipment market is available : https://www.mraccuracyreports.com/report-sample/533552“The Global Ultrasonic Diagnostic Equipment Market size was estimated at a reasonable million USD in 2021 and expected to reach a healthy million USD in 2022, and is projected to grow at a steady CAGR to get a prominent million USD by 2027.”The market was studied across External Ultrasonic Diagnostic Equipment and Internal Ultrasonic Diagnostic Equipment based on Category. Report provides a basic overview of the industry including definitions, classifications, applications and Ultrasonic Diagnostic Equipment industry chain structure. Top Companies in this report are: Samsung Medison, Philips, Konica Minolta, Hitachi Medical Systems, FUJIFILM SonoSite, Canon Medical Systems, Boston Scientific, BenQ Medical Technology, Alpinion Medical Systems, AbbottUltrasonic Diagnostic Equipment Market Overview:Ultrasonic Diagnostic Equipment Market research is an intelligence report with meticulous efforts to study the right and valuable information. The data considers both the existing top players and the upcoming internet competitors. Global Forecast to 2027 latest report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the Ultrasonic Diagnostic Equipment market.This market research report is a compilation of informative data that gives an all-inclusive analysis of the current trend for the forecast period. Our report offers a comprehensive account of the current state of the market and describes its future prospects as well. We also illustrate how to make future business plans based on our predictions.SegmentationThe report offers an in-depth assessment of the Ultrasonic Diagnostic Equipment market strategies, geographic and business segments of the key players in the market, also provides insights on current and future market trends, prominent regional market analysis and industry chain analysis of the global and regional Ultrasonic Diagnostic Equipment markets.Ultrasonic Diagnostic Equipment Market Segmentation by Type:Continuous Wave Ultrasound Equipment, Pulsed Wave Ultrasound Equipment.Ultrasonic Diagnostic Equipment Market Segmentation by Application:Hospitals, Clinics, OtherThe Ultrasonic Diagnostic Equipment market was studied across the Americas, Asia-Pacific, Europe, Middle East & Africa based on region. The Americas is further explored Ultrasonic Diagnostic Equipment report across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied Ultrasonic Diagnostic Equipment report across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further analyzed Ultrasonic Diagnostic Equipment report across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Finally, Europe, the Middle East & Africa is further studied. Ultrasonic Diagnostic Equipment report across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and the United Kingdom.Access full Report Description, TOC, Table of figures, Chart, etc.: https://www.mraccuracyreports.com/reportdetails/reportview/533552Cumulative Impact of COVID-19 on Ultrasonic Diagnostic Equipment report:Our ongoing Ultrasonic Diagnostic Equipment report research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. In addition, the updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Ultrasonic Diagnostic Equipment market.The Porter Matrix evaluates and categorizes the Ultrasonic Diagnostic Equipment vendors in the market based on Business Strategy (Industry Coverage, Business Growth, Financial Viability, and Channel Support) and Ultrasonic Diagnostic Equipment Product Satisfaction (Ease of Use, Product Features, Value for Money, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Ultrasonic Diagnostic Equipment Market Share Analysis: Knowing Ultrasonic Diagnostic Equipment’s market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the Ultrasonic Diagnostic Equipment market characteristics in accumulation, dominance, fragmentation, and amalgamation traits.The report answers questions such as:What is the Ultrasonic Diagnostic Equipment market size and forecast of the Global Market?What are the inhibiting factors and impact of COVID-19 shaping the Global Ultrasonic Diagnostic Equipment Market during the forecast period?Which products/segments/applications/areas to invest in over the forecast period in the Global Ultrasonic Diagnostic Equipment Market?What modes and strategic moves are suitable for entering the Global Ultrasonic Diagnostic Equipment Market?Direct Purchase this Market Research Report Now @ https://www.mraccuracyreports.com/checkout/533552If you have any special requirements, please let us know and we will offer you the report as you want. – Trending In Global

Ultrasonic Diagnostic Equipment Market Size And Forecast -Samsung Medison, Philips, Konica Minolta, Hitachi Medical Systems, FUJIFILM SonoSite, Canon Medical Systems, Boston Scientific, BenQ Medical Technology, Alpinion Medical Systems, Abbott Mr Accuracy Reports announces the release of the report ‘ Ultrasonic Diagnostic Equipment Market Research Report by Category, form, Product, Type, End-User, Region…

Continue Reading Ultrasonic Diagnostic Equipment Market Size And Forecast -Samsung Medison, Philips, Konica Minolta, Hitachi Medical Systems, FUJIFILM SonoSite, Canon Medical Systems, Boston Scientific, BenQ Medical Technology, Alpinion Medical Systems, Abbott Mr Accuracy Reports announces the release of the report ‘ Ultrasonic Diagnostic Equipment Market Research Report by Category, form, Product, Type, End-User, Region – Global Forecast to 2027. The primary drivers of this growth are the increasing need for market information and sustainability of key trends.’ The internet industry report further includes market shortcomings, stability, growth drivers, restraining factors, opportunities over the forecast period. Our market research report forecasts in depth comprehensive analysis of the global market, presenting you with the newest insights of our leading analysts.Get an Exclusive Sample of Report on the Ultrasonic Diagnostic Equipment market is available : https://www.mraccuracyreports.com/report-sample/533552“The Global Ultrasonic Diagnostic Equipment Market size was estimated at a reasonable million USD in 2021 and expected to reach a healthy million USD in 2022, and is projected to grow at a steady CAGR to get a prominent million USD by 2027.”The market was studied across External Ultrasonic Diagnostic Equipment and Internal Ultrasonic Diagnostic Equipment based on Category. Report provides a basic overview of the industry including definitions, classifications, applications and Ultrasonic Diagnostic Equipment industry chain structure. Top Companies in this report are: Samsung Medison, Philips, Konica Minolta, Hitachi Medical Systems, FUJIFILM SonoSite, Canon Medical Systems, Boston Scientific, BenQ Medical Technology, Alpinion Medical Systems, AbbottUltrasonic Diagnostic Equipment Market Overview:Ultrasonic Diagnostic Equipment Market research is an intelligence report with meticulous efforts to study the right and valuable information. The data considers both the existing top players and the upcoming internet competitors. Global Forecast to 2027 latest report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the Ultrasonic Diagnostic Equipment market.This market research report is a compilation of informative data that gives an all-inclusive analysis of the current trend for the forecast period. Our report offers a comprehensive account of the current state of the market and describes its future prospects as well. We also illustrate how to make future business plans based on our predictions.SegmentationThe report offers an in-depth assessment of the Ultrasonic Diagnostic Equipment market strategies, geographic and business segments of the key players in the market, also provides insights on current and future market trends, prominent regional market analysis and industry chain analysis of the global and regional Ultrasonic Diagnostic Equipment markets.Ultrasonic Diagnostic Equipment Market Segmentation by Type:Continuous Wave Ultrasound Equipment, Pulsed Wave Ultrasound Equipment.Ultrasonic Diagnostic Equipment Market Segmentation by Application:Hospitals, Clinics, OtherThe Ultrasonic Diagnostic Equipment market was studied across the Americas, Asia-Pacific, Europe, Middle East & Africa based on region. The Americas is further explored Ultrasonic Diagnostic Equipment report across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied Ultrasonic Diagnostic Equipment report across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further analyzed Ultrasonic Diagnostic Equipment report across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Finally, Europe, the Middle East & Africa is further studied. Ultrasonic Diagnostic Equipment report across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and the United Kingdom.Access full Report Description, TOC, Table of figures, Chart, etc.: https://www.mraccuracyreports.com/reportdetails/reportview/533552Cumulative Impact of COVID-19 on Ultrasonic Diagnostic Equipment report:Our ongoing Ultrasonic Diagnostic Equipment report research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. In addition, the updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Ultrasonic Diagnostic Equipment market.The Porter Matrix evaluates and categorizes the Ultrasonic Diagnostic Equipment vendors in the market based on Business Strategy (Industry Coverage, Business Growth, Financial Viability, and Channel Support) and Ultrasonic Diagnostic Equipment Product Satisfaction (Ease of Use, Product Features, Value for Money, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Ultrasonic Diagnostic Equipment Market Share Analysis: Knowing Ultrasonic Diagnostic Equipment’s market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the Ultrasonic Diagnostic Equipment market characteristics in accumulation, dominance, fragmentation, and amalgamation traits.The report answers questions such as:What is the Ultrasonic Diagnostic Equipment market size and forecast of the Global Market?What are the inhibiting factors and impact of COVID-19 shaping the Global Ultrasonic Diagnostic Equipment Market during the forecast period?Which products/segments/applications/areas to invest in over the forecast period in the Global Ultrasonic Diagnostic Equipment Market?What modes and strategic moves are suitable for entering the Global Ultrasonic Diagnostic Equipment Market?Direct Purchase this Market Research Report Now @ https://www.mraccuracyreports.com/checkout/533552If you have any special requirements, please let us know and we will offer you the report as you want. – Trending In Global

Researchers Go Beyond Gene Variant Analysis With Nascent Pangenome-Based Methods

NEW YORK – Graph-based genomes, such as the one being built by the Human Pangenome Reference Consortium (HPRC), are already being used to do more than just genetic variant analysis. Last week, researchers from the University of California, Santa Cruz published a paper in Nature Methods showing how a graph…

Continue Reading Researchers Go Beyond Gene Variant Analysis With Nascent Pangenome-Based Methods

Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research

CORALVILLE, Iowa–(BUSINESS WIRE)–To help researchers accurately measure circulating tumor DNA (ctDNA) from the most degraded and low-input samples, Integrated DNA Technologies today launched a complete MRD workflow for tumor-informed approaches. The launch expands access to IDT’s xGen MRD Hybridization Panel and xGen cfDNA & FFPE DNA Library Preparation Kit, which…

Continue Reading Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research

Postdoctoral Fellow Uhlmann Research Group at European Molecular Biology Laboratory (EMBL)

About the team/job Chronic kidney failure affects about 11% of the world population, of which one-third of cases involve immune-mediated disease. Those patients who reach end-stage kidney failure require renal replacement therapy, and though transplantation considerably improves the quality of life, the longevity of transplant organs is limited, mainly due…

Continue Reading Postdoctoral Fellow Uhlmann Research Group at European Molecular Biology Laboratory (EMBL)

Hemato Oncology Testing Market to Witness Massive Growth by Abbott Laboratories, Thermo Fisher Scientific, QIAGEN N.V.

The Global Hemato Oncology Testing Market 2032 Industry Report is a professional and in-depth study on the current state of the Hemato Oncology Testing Market by QMI. The Hemato Oncology Testing Market is supposed to demonstrate a considerable growth during the forecast period of 2023-2032. The company profiles of all…

Continue Reading Hemato Oncology Testing Market to Witness Massive Growth by Abbott Laboratories, Thermo Fisher Scientific, QIAGEN N.V.

Adakveo Fails to Reduce SCD Crises in Latest Phase 3 Trial | Data Do Not Match Results of Trial That Led to Therapy’s Approval

Treatment with Adakveo (crizanlizumab) did not reduce the yearly occurrence of painful vaso-occlusive crises (VOCs) leading to a medical visit, as compared with a placebo, in people with sickle cell disease (SCD), according to preliminary data from an ongoing Phase 3 trial. The study, called STAND (NCT03814746), is testing Novartis’ Adakveo…

Continue Reading Adakveo Fails to Reduce SCD Crises in Latest Phase 3 Trial | Data Do Not Match Results of Trial That Led to Therapy’s Approval

Global In-Vitro Colorectal Cancer Screening Tests Market to

New York, Jan. 31, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global In-Vitro Colorectal Cancer Screening Tests Industry” – www.reportlinker.com/p05895895/?utm_source=GNW Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest…

Continue Reading Global In-Vitro Colorectal Cancer Screening Tests Market to

Plans put forward for 71-storey Manchester tower

Plans have been unveiled for a 71-storey tower in Manchester, which if given the go-ahead would be the city’s tallest building. Developer and builder Renaker announced it wants to construct the 71-storey, primarily residential, block incorporating 642 apartments, a top-floor swimming pool for residents and publicly accessible restaurant, also on…

Continue Reading Plans put forward for 71-storey Manchester tower

Study demonstrates intrahost MPXV variation within a single lesion

In a recent study published in Emerging Infectious Diseases, researchers reported on the clinical and molecular characteristics of monkeypox (MPX) virus (MPXV) infections in Finland. Study: Intrahost Monkeypox Virus Genome Variation in Patient with Early Infection, Finland, 2022. Image Credit: ART-ur/Shutterstock Background Ever since 2022, an unprecedented MPXV outbreak has…

Continue Reading Study demonstrates intrahost MPXV variation within a single lesion

Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients

Researchers from Amsterdam University Medical Centers (UMC) have found that carriers of specific hidden bacteria have a 14% chance of developing an antibiotic-resistant infection within 30 days of hospitalization. The research, published January 30 in the Lancet Infectious Diseases, studied patients who were unknowingly carrying the multidrug-resistant Gram-negative bacteria, a…

Continue Reading Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients

Scientists begin project to bring back the extinct dodo

The dodo is one of the most famous extinct creatures on the planet — but is there a chance it could be brought back to life? Well, with advances in science and thanks to the first successful sequencing of the flightless bird’s entire genome last year, experts think that’s a possibility. US…

Continue Reading Scientists begin project to bring back the extinct dodo

Ivanhoe Mines Announces Capital Expenditure Guidance to First Production for Kamoa-Kakula Phase 3, Platreef (Phase 1) and Kipushi

Kamoa-Kakula Phase 3 and future expansion capital costs expected to be funded by operating cash flow, at current copper prices Platreef Phase 1 initial capital currently funded with proceeds from stream facility; $150 million senior debt facility progressing well Kipushi construction activities underway, with pre-payment financing and offtake discussions nearing completion…

Continue Reading Ivanhoe Mines Announces Capital Expenditure Guidance to First Production for Kamoa-Kakula Phase 3, Platreef (Phase 1) and Kipushi

Resurrecting the Dodo: How Scientists Plan to De-Extinct an Iconic Species

The wildlife of Mauritius, a tropical island in the Indian Ocean about 500 miles east of Madagascar, couldn’t have known that the giant shadows cast across the bay in 1598 would signal doom.  A fleet of Dutch ships had arrived, mirroring the Chicxulub asteroid that had crashed into in the…

Continue Reading Resurrecting the Dodo: How Scientists Plan to De-Extinct an Iconic Species

Eurojobs.com: Software Engineer – Bioinformatics

One of the world’s leading corporations in the Diagnostics and Life Science Research Sector is looking for a Software Engineer to work for one of their fasted developing subsidiaries in the spatial biology field. They are looking for someone with a strong biology background to use their industry and technical…

Continue Reading Eurojobs.com: Software Engineer – Bioinformatics

Rain Oncology receives Buy rating from Roth

Roth Capital Partners renewed coverage of Rain Oncology (Rain Oncology Stock Quote, Charts, News, Analysts, Financials NASDAQ:RAIN) on Tuesday, with Roth analyst Kumaraguru Raja saying there’s a favourable risk-reward on the stock heading into a data readout during the present quarter. Newark, CA-based Rain Oncology is a development stage precision…

Continue Reading Rain Oncology receives Buy rating from Roth

Scientists plot the resurrection of a bird that’s been extinct since the 17th century

No other animal is as inexorably linked with extinction as the dodo, an odd-looking flightless bird that lived on the island of Mauritius in the Indian Ocean until the late 17th century. The arrival of sailors brought with them invasive species like rats and practices like hunting. They doomed the…

Continue Reading Scientists plot the resurrection of a bird that’s been extinct since the 17th century

CRISPR Market Size and Market Drivers Analysis 2023

PRESS RELEASE Published January 30, 2023 CRISPR Market Analysis 2023 by Major Key Players (Intellia Therapeutics, Inc., Transposagen Biopharmaceuticals, Inc., CRISPR Therapeutics, Integrated DNA Technologies, Inc., GE Healthcare Dharmacon Inc, Thermo Fisher Scientific, Inc., Addgene, GenScript Biotech Corporation and more) Research Report by Absolute Reports “Final Report will add the…

Continue Reading CRISPR Market Size and Market Drivers Analysis 2023

Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)

Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measures In-Vivo Activity based on Mechanism of Action Assay Identifies High-Potency Product Lots Associated with Enhanced Survival New Data Show that Remestemcel-L Improves Inflammatory Biomarkers and Survival in Children at Highest Risk of Mortality New 4-Year Data from…

Continue Reading Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)

Characterization of the bacterial microbiome of Swedish ticks through 16S rRNA amplicon sequencing of whole ticks and of individual tick organs

Background: The composition of the microbial flora associated with ixodid ticks has been studied in several species, revealing the importance of geographical origin, developmental stage(s) and feeding status of the tick, as well as substantial differences between tissues and organs. Studying the microbiome in the correct context and scale is…

Continue Reading Characterization of the bacterial microbiome of Swedish ticks through 16S rRNA amplicon sequencing of whole ticks and of individual tick organs

Dr. Fran Supek receives an ERC Consolidator g

image: Dr. Fran Supek view more  Credit: IRB Barcelona The project to be carried out at IRB Barcelona has been awarded €2M to address an understudied mutation type known as structural variants. Using machine learning approaches, as well as innovative sequencing techniques, the laboratory will study the role of these mutations…

Continue Reading Dr. Fran Supek receives an ERC Consolidator g

Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures

doi: 10.7554/eLife.83138. Affiliations Expand Affiliations 1 Department of Orthopaedics, Emory University, Atlanta, United States. 2 Atlanta VA Medical Center, Decatur, United States. 3 School of Chemical Materials and Biomedical Engineering, University of Georgia, Athens, United States. 4 Regenerative Bioscience Center, E.L. Rhodes Center for ADS, University of Georgia, Athens, United…

Continue Reading Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures

Bug Bounty Radar // The latest bug bounty programs for February 2023

New web targets for the discerning hacker A bypass of Facebook’s SMS-based two-factor authentication (2FA) made it into Meta’s most impressive bug bounty finds of 2022. However, it seems Facebook’s parent company initially didn’t fully appreciate the vulnerability, offering a $3,000 bounty before eventually revising the reward upwards to $27,200….

Continue Reading Bug Bounty Radar // The latest bug bounty programs for February 2023

Europe Bioinformatics Market Growing at Eminent CAGR of 19.05% by 2029

PRESS RELEASE Published January 31, 2023 Europe Bioinformatics market survey report deals with the recent business challenges and investigates research on market which includes market attributes, industry structure, and competitive scenario, the problems, desire concepts, together with business strategies and market effectiveness. All the market insights of the report are…

Continue Reading Europe Bioinformatics Market Growing at Eminent CAGR of 19.05% by 2029

Belite Bio : Submits IND Amendment to Initiate Phase 3 Clinical Trial of Tinlarebant (LBS-008) in Advanced Dry AMD

Belite Bio Submits IND Amendment to Initiate Phase 3 Clinical Trial of Tinlarebant (LBS-008) in Advanced Dry AMD February 1, 2023 Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to halt or slow disease progression in patients affected with Stargardt Disease (STGD1) and Dry Age-related Macular Degeneration (Dry…

Continue Reading Belite Bio : Submits IND Amendment to Initiate Phase 3 Clinical Trial of Tinlarebant (LBS-008) in Advanced Dry AMD

Clinical Diagnostic Application Segment Anticipated to be the Most Attractive During 2023- 2033

Request For Free Sample Report of “Metagenomics Market”@ www.persistencemarketresearch.com/samples/25099 Metagenomics plays an important role in bioremediation as microorganisms are the main agents of bioremediation. Microorganisms are responsible for degradation of environmental pollutants. The metagenome of a contaminated environment includes all the DNA involved in that environment. Genetic information is used to…

Continue Reading Clinical Diagnostic Application Segment Anticipated to be the Most Attractive During 2023- 2033

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

Dr. Ray Chen of GenScript in interaction with BioPharma APAC, reveals an aim to help accelerate the development of these therapies from research to clinic by providing high-quality cGMP sgRNA, Cas9 nuclease, and non-viral DNA payloads (ssDNA/dsDNA/circular minimized dsDNA) with fast turnaround time How is GenScript planning to meet the…

Continue Reading GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

Intern in Process Development for Upstream Cell Manufacturing of iPSCs in large scale systems(f/m/d) at Bayer in Wuppertal, North-Rhine-Westphalia 783844

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us,…

Continue Reading Intern in Process Development for Upstream Cell Manufacturing of iPSCs in large scale systems(f/m/d) at Bayer in Wuppertal, North-Rhine-Westphalia 783844

Next Generation Sequencing (NGS) Market Growth Opportunities and Competitive Scenario 2032

Next Generation Sequencing (NGS) Market: Analysis and Insights Next Generation Sequencing (NGS) Market report provides details of market share, new developments and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product…

Continue Reading Next Generation Sequencing (NGS) Market Growth Opportunities and Competitive Scenario 2032

A ‘De-Extinction’ Company Wants to Bring Back the Dodo

Colossal Biosciences, the headline-grabbing, venture-capital-funded juggernaut of de-extinction science, announced plans on January 31 to bring back the dodo. Whether “bringing back” a semblance of the extinct flightless bird is feasible is a matter of debate. Founded in 2021 by tech entrepreneur Ben Lamm and Harvard University geneticist George Church,…

Continue Reading A ‘De-Extinction’ Company Wants to Bring Back the Dodo

We Could See The Return Of A Certain Prehistoric Creature In Our Lifetime

The proposed ice age creature is the woolly mammoth. Colossal hopes to revive it as soon as 2027, and it would be less of a clone and more of a genetic hybrid made possible with CRISPR-Cas9 DNA splicing technology, according to NPR. Theoretically, once mammoth DNA is genetically spliced with the…

Continue Reading We Could See The Return Of A Certain Prehistoric Creature In Our Lifetime

Council Of Europe Warns Over Data Protection Rights

The Council of Europe has warned that human rights including data protection are under threat by the “bleak picture” created by international crises such as the conflict in Ukraine and economic turbulence. The warning coincides with the annual Data Protection Day on 28 January, a date initiated by the Council…

Continue Reading Council Of Europe Warns Over Data Protection Rights

MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health

DUBAI, UAE, Jan. 30, 2023 /PRNewswire/ —  MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, will introduce many of its latest gene sequencing platforms and sample preparation system at MEDLAB Middle East 2023, taking place 6-9 February in Dubai. Ahead of…

Continue Reading MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health

DNA sheds new light on Greenland’s past

Ewen Callaway* says ancient DNA material, collected from the permafrost of northern Greenland, reveals that mastodons and reindeer once roamed through lush forests there.   Today, the north-eastern tip of Greenland is a lonely, barren place, home to the odd hare and musk ox, and a few hardy plants. However, two-million-year-old DNA sequences…

Continue Reading DNA sheds new light on Greenland’s past

Next Generation Sequencing Market Business Strategies,

Next Generation Sequencing Market The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the next-generation sequencing market report by The Business Research Company, the growing number of cases with chronic conditions such as…

Continue Reading Next Generation Sequencing Market Business Strategies,

Research associate (f/m/d) PostDoc Biology, Bioinformatics

Located in Brunswick, Germany. The Thünen Institute of Forest Genetics, one of the 15 Federal Research Institutes for Rural Areas, Forestry and Fisheries in Germany, is offering a 1,5-year position (100 %) starting as soon as possible for a research associate (f/m/d) (PostDoc Biology, Bioinformatics) to study genomic patterns of…

Continue Reading Research associate (f/m/d) PostDoc Biology, Bioinformatics

Global Metagenomics Market 2023: Clinical Diagnostic

The Metagenomics Market is an emerging segment of the healthcare industry. Metagenomics is a “bottom-up” approach to studying the entire gene makeup of microbial communities without having to culture them in a lab setting. This allows for greater insight into how microbes interact with each other and their environment, as…

Continue Reading Global Metagenomics Market 2023: Clinical Diagnostic

The human genome needs updating. But how do we make it fair? | Genetics

In June 2000, Bill Clinton, the then US president, stood smilingly next to the leaders of the Human Genome Project. “In genetic terms, all human beings, regardless of race, are more than 99.9% the same,” he declared. That was the message when the first draft of the human genome sequence…

Continue Reading The human genome needs updating. But how do we make it fair? | Genetics

Has DNA sequencing expert Illumina taken the wrong path in search of holy grail?

In September, the world’s biggest genome sequencing company hosted Barack Obama, Bill Gates and other luminaries at its annual forum in San Diego, predicting its latest generation of machines would help “change the world”. Illumina could make the case that it had already done so with its existing technology. It…

Continue Reading Has DNA sequencing expert Illumina taken the wrong path in search of holy grail?

Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that control lysosome positioning in the bladder cancer model

Cell culture and treatments Bladder cancer cells lines RT4, MGHU3, RT112, KU19-19, JMSU1, T24 and TCCSup were grown in RPMI-1640 medium (Life Technologies, Carlsbad, CA, USA), supplemented with 10% Fetal Bovine Serum (FBS; Eurobio, Courtaboeuf, France). Normal human urothelium (NHU) cells were from Jennifer Southgate (University of York, UK). NHU were…

Continue Reading Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that control lysosome positioning in the bladder cancer model

PolaR-ICE Effective as Second-line Treatment in DLBCL, Bridge to Autologous Stem Cell Transplant

Adding polatuzumab vedotin (polatu-zumab, Polivy) to rituximab-based salvage therapy produced strong responses and allowed 61% of patients who had failed their first treatment for diffuse large B-cell lymphomas (DLBCL) to successfully bridge to autologous stem cell transplant (ASCT), according to a phase 2 study (NCT04665765).1 Results from 41 patients, presented…

Continue Reading PolaR-ICE Effective as Second-line Treatment in DLBCL, Bridge to Autologous Stem Cell Transplant

First detection of Ixodiphagus hookeri (Hymenoptera: Encyrtidae) in Ixodes ricinus ticks (Acari: Ixodidae) from multiple locations in Hungary

Chala, B. & Hamde, F. Emerging and re-emerging vector-borne infectious diseases and the challenges for control: A review. Front. Public Health doi.org/10.3389/fpubh.2021.715759 (2021). Article  Google Scholar  Jongejan, F. & Uilenberg, G. The global importance of ticks. Parasitology 129, S3–S14 (2004). Google Scholar  Hornok, S., Kováts, D., Horváth, G., Kontschán, J….

Continue Reading First detection of Ixodiphagus hookeri (Hymenoptera: Encyrtidae) in Ixodes ricinus ticks (Acari: Ixodidae) from multiple locations in Hungary

Whole Transcriptomics Sequencing Market 2023 Extensive

Whole Transcriptomics Sequencing Whole Transcriptomics Sequencing Market Report Forecast to 2023-2030 provides deep market insights to assist firms in making better business decisions and driving growth plans, based on prediction and market trends. The dynamic market structure, key players product offerings, their challenges, technical innovation, obstacles and barriers, information on…

Continue Reading Whole Transcriptomics Sequencing Market 2023 Extensive

Bioinformatics Services Market is expected to grow from USD 2.8 billion in 2022 to USD 8.7 billion by 2030 : GreyViews

Pune India, Jan. 28, 2023 (GLOBE NEWSWIRE) — The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the bioinformatics services market is operating and is predicted to expand…

Continue Reading Bioinformatics Services Market is expected to grow from USD 2.8 billion in 2022 to USD 8.7 billion by 2030 : GreyViews

Molecular epidemiology of CRKP | IDR

Introduction Klebsiella pneumoniae (Kp; K. pneumoniae) is an important hospital and community-acquired pathogen that primarily causes pneumonia, urinary tract infections, bloodstream-associated infections, meningitis, and pyogenic liver abscess.1–3 Carbapenem antibiotics represent the most important treatment for Enterobacteriaceae; however, with the widespread use of such antibiotics, carbapenem-resistant K. pneumoniae (CRKP) is increasingly…

Continue Reading Molecular epidemiology of CRKP | IDR

Bioinformatics Jobs in Belfast, Northern Ireland

There is 1 Bioinformatics opportunity available in Belfast, UK all with unique requirements. We know that finding a job as a Bioinformatics can get a little overwhelming, but it’s actually less stressful than you think. All you have to do is start your search on Joblist. Here, you will indeed…

Continue Reading Bioinformatics Jobs in Belfast, Northern Ireland

Profitable Strategic Report on Gene Amplification Technologies Market With Included Analysis of New Trends, Updates, and Forecast to 2030 QIAGEN, New England Biolabs, Illumina Inc., Yikang Gene

The Worldwide Gene Amplification Technologies Market Research Report 2022 is Carefully conducted for the industry in a qualitative and consistent way to ensure a successful outcome for the Gene Amplification Technologies Market. In addition to identifying, analyzing, and estimating new trends, this research report also examines key industry drivers, challenges,…

Continue Reading Profitable Strategic Report on Gene Amplification Technologies Market With Included Analysis of New Trends, Updates, and Forecast to 2030 QIAGEN, New England Biolabs, Illumina Inc., Yikang Gene

Movements in proteins reveal information about antibiotic resistance spreading

The PriRep5 cryoEM structure. (A) The PriRep5 map processed in C1. Only the CTDs of subunits A, B and C were visible in the C1 map. Letters match the color code of subunits in (B). On the right, a transparent pink PriRep5 map processed in C6 and docked with the…

Continue Reading Movements in proteins reveal information about antibiotic resistance spreading

Rapid emergence of extensively drug-resistant Shigella sonnei in France

Antimicrobial susceptibility data of S. sonnei in France Our review of S. sonnei antimicrobial susceptibility data obtained between 2005 and 2021 (based on 7121 isolates received and confirmed at the French National Reference Center for E. coli, Shigella and Salmonella, FNRC-ESS, Institut Pasteur) revealed a sharp increase in the percentage…

Continue Reading Rapid emergence of extensively drug-resistant Shigella sonnei in France

Fluorescent aptasensor based on the MNPs-CRISPR/Cas12a-TdT for the determination of nasopharyngeal carcinoma-derived exosomes

doi: 10.1007/s00604-023-05657-7. Affiliations Expand Affiliations 1 Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430074, Hubei, China. 2 Department of Pharmacy, Zigong Third People’s Hospital, Zigong, 643020, Sichuan, China. 3 Department of Otorhinolaryngology Head and Neck Surgery, Shenzhen Fuyong People’s Hospital, Shenzhen,…

Continue Reading Fluorescent aptasensor based on the MNPs-CRISPR/Cas12a-TdT for the determination of nasopharyngeal carcinoma-derived exosomes

Variants studied for intestinal disease due to fat malabsorption

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells. pathogenic likely pathogenic uncertain significance likely benign benign not provided total 59…

Continue Reading Variants studied for intestinal disease due to fat malabsorption

Artificial Intelligence in Genomics Market Industry Analysis –

The Global Artificial Intelligence in Genomics Market size accounted for USD 471 Million in 2021 and is estimated to reach USD 18,213 Million by 2030. Artificial Intelligence in Genomics Market Dynamics The rapid expansion of genomics research data sets, the emergence of startups in the sector, and significant research and…

Continue Reading Artificial Intelligence in Genomics Market Industry Analysis –

Species richness of bat flies and their associations with host bats in a subtropical East Asian region | Parasites & Vectors

Scott M, Dobson A. The role of parasites in regulating host abundance. Parasitol Today. 1989;5:176–83. CAS  Google Scholar  Tompkins D, Dobson A, Arneberg P, Begon M, Cattadori I, Greenman J, et al. Parasites and host population dynamics. The ecology of wildlife diseases. 2002; 45–62. Thomas F, Poulin R, Brodeur J….

Continue Reading Species richness of bat flies and their associations with host bats in a subtropical East Asian region | Parasites & Vectors

Multiplexed Diagnostic Market is booming with a large industrial scope

The multiplexed diagnostic assay is used to identify multiple analytes in a single run cycle. Multiplex assay is used in the detection of defects such as mutation in functional biomolecules (DNA, mRNA, and protein) with the help of DNA microarray, multiplex PCR, and next-generation sequencing. The Global Multiplexed Diagnostic Market…

Continue Reading Multiplexed Diagnostic Market is booming with a large industrial scope

Does Ancient Egyptian mummies not have any DNA left? –

Scientists have come up with reliable ways to sequence and check DNA, and used Egyptian mummies to do the first successful genomic tests. The problem, it was thought, is that Egyptian mummy DNA couldn’t be sequenced. But a group of international researchers, using unique methods, have overcome the barriers to…

Continue Reading Does Ancient Egyptian mummies not have any DNA left? –

Clinical Metagenomic Next Generation Sequencing Market

Clinical Metagenomic Next Generation Sequencing Market The Clinical Metagenomic Next Generation Sequencing Market Report examines many facets of the industry including market size, market status, market trends, and forecasts. The report also provides brief information on specific growth opportunities by competitors and key market drivers. The Market Report provides In-depth…

Continue Reading Clinical Metagenomic Next Generation Sequencing Market

New Technology Developments in CRISPR and CAS Gene Market to Grow

CRISPR and CAS Gene Market The CRISPR and CAS Gene Market Report Overview 2022 Qualitative Research Study accomplished by Stratagem Market Insights research’s database of 350 pages, titled “Global CRISPR and CAS Gene Market Study” with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand…

Continue Reading New Technology Developments in CRISPR and CAS Gene Market to Grow

Research Associate in Stem Cell Neurobiology job with KINGS COLLEGE LONDON

  Job description We are looking for a skilled research associate with a molecular biological background to join a vibrant group investigating amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD). You will be using CRISPR to gene edit human stem cells to introduce unpublished disease-linked mutations. This work will entail the use of…

Continue Reading Research Associate in Stem Cell Neurobiology job with KINGS COLLEGE LONDON

Gilead’s CAR-T cell therapy recommended by NICE for lymphoma

Gilead Science and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel) to treat certain forms of lymphoma. Specifically, the therapy is now recommended for adult patients with diffuse large B-cell lymphoma (DLBCL) or primary mediastinal large B-cell…

Continue Reading Gilead’s CAR-T cell therapy recommended by NICE for lymphoma

Mutational Signatures Profiled in Pediatric Cancers

NEW YORK – A team led by researchers in Germany has systematically analyzed mutational signatures across more than two dozen pediatric cancer types or subtypes, providing a look at everything from processes behind the tumors to potential features or vulnerabilities linked to certain tumor subtypes. Co-senior authors Natalie Jager and…

Continue Reading Mutational Signatures Profiled in Pediatric Cancers

The Global Bioinformatics Market size is expected to reach $19.9 billion by 2028, rising at a market growth of 12.5% CAGR during the forecast period

ReportLinker In order to serve several fields of scientific study, including biomedicine, bioinformatics—a mix of biology and information technology—links biological data with methods for information storage, dissemination, and analysis. New York, Jan. 27, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Bioinformatics Market Size, Share &…

Continue Reading The Global Bioinformatics Market size is expected to reach $19.9 billion by 2028, rising at a market growth of 12.5% CAGR during the forecast period

Thomas Vernier Earns International Award for Outstanding Achievements in Bioelectrics

By David Simpson In his laboratory at the Frank Reidy Research Center for Bioelectrics, Thomas Vernier bombards cells and tissue with short pulses of high-voltage electrical fields. Extremely short pulses. Billionths of a second. This technique, pioneered at the Old Dominion University center, is powerful enough to open pores in…

Continue Reading Thomas Vernier Earns International Award for Outstanding Achievements in Bioelectrics

GOplots::GOChord with heatmaps?

GOplots::GOChord with heatmaps? 0 @adrijakalvisa-22810 Last seen 16 hours ago Denmark Hi all, is there a way to add a gene expression heatmap option to GOplots::GOChord plot? Or multiple heatmaps at once? An example Chord plot: Fig 6 in PMID: 33674625. Here is what I tried: library(GOplot) data(EC) circ <-…

Continue Reading GOplots::GOChord with heatmaps?

Remote Visualization of Local Genome Alignments Aids Pathogenic Variant Evaluation for Rare Disease

CHICAGO – A group at Spain’s National Center for Genomic Analysis-Center for Genomic Regulation (CNAG-CRG) in Barcelona has harnessed a protocol for accessing sequencing and variant data to help assess potentially pathogenic genetic variants within the context of a European Union-funded program to improve diagnosis of rare diseases. The CNAG-CRG…

Continue Reading Remote Visualization of Local Genome Alignments Aids Pathogenic Variant Evaluation for Rare Disease

Allergy Diagnostics Market Size & Share to Surpass $8873.68

WASHINGTON, Jan. 27, 2023 (GLOBE NEWSWIRE) — Vantage Market Research analyses that the Allergy Diagnostics Market which was $ 4821.90 Million in 2021, would rocket up to $ 8873.68 Million by 2028, and is expected to undergo a CAGR of 10.70% during the forecast period 2022 to 2028. Vantage Market…

Continue Reading Allergy Diagnostics Market Size & Share to Surpass $8873.68

Biosimilar Equal to Natalizumab for Relapsing-Remitting MS

An agent biologically similar to the humanized monoclonal antibody natalizumab is as effective and safe as the original reference drug for relapsing-remitting multiple sclerosis (RRMS) — and has a similar level of immunogenicity, new research shows. Investigators note that these phase 3 trial findings are the final stage in the…

Continue Reading Biosimilar Equal to Natalizumab for Relapsing-Remitting MS

DNA in the Trenches: How to Identify Fallen Soldiers | Office for Science and Society

Last week, we were told that DNA performed a bit of a miracle: it identified a man who was born in 1894 and who died during the First World War. His name was Percy Howarth. He was born in Lancashire, England, and moved to Canada a few years before enlisting…

Continue Reading DNA in the Trenches: How to Identify Fallen Soldiers | Office for Science and Society

New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More

Qiagen CLC Genomics Workbench Premium Qiagen Digital Insights has released an update to its Qiagen CLC Genomics Workbench Premium, incorporating a software accelerator called LightSpeed for faster analysis of next-generation sequencing data. The company said that this technology will allow laboratories to process a genome sequenced at 34X depth in 25 minutes for…

Continue Reading New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More

Whole genome sequencing revealed genetic diversity, population structure, and selective signature of Panou Tibetan sheep | BMC Genomics

Zhao E, Yu Q, Zhang N, Kong D, Zhao Y. Mitochondrial DNA diversity and the origin of Chinese indigenous sheep. Trop Anim Health Prod. 2013;45(8):1715-22. Liu J, Ding X, Zeng Y, Yue Y, Guo X, Guo T, et al. Genetic diversity and phylogenetic evolution of Tibetan sheep based on mtDNA D-loop…

Continue Reading Whole genome sequencing revealed genetic diversity, population structure, and selective signature of Panou Tibetan sheep | BMC Genomics

Wild deer (Pudu puda) from Chile harbor a novel ecotype of Anaplasma phagocytophilum | Parasites & Vectors

Rar V, Tkachev S, Tikunova N. Genetic diversity of Anaplasma bacteria: twenty years later. Infect Genet Evol. 2021;91:104833. Google Scholar  Atif FA. Alpha proteobacteria of genus Anaplasma (Rickettsiales: Anaplasmataceae): epidemiology and characteristics of Anaplasma species related to veterinary and public health importance. Parasitology. 2016;143:659–85. Google Scholar  Battilani M, de Arcangeli…

Continue Reading Wild deer (Pudu puda) from Chile harbor a novel ecotype of Anaplasma phagocytophilum | Parasites & Vectors

Time-dependent microbial shifts during crayfish decomposition in freshwater and sediment under different environmental conditions

Seilacher, A. Arbeitskonzept zur konstruktions-morphologie. Lethaia 3, 393–396 (1970). Google Scholar  Seilacher, B. A., Reif, W.-E. & Westphal, F. Sedimentological, ecological and temporal patterns of fossil Lagerstätten. Philos. Trans. R. Soc. Lond. B 311, 5–23 (1985). ADS  Google Scholar  Gibbons, N. E. & Reed, G. B. The effect of autolysis…

Continue Reading Time-dependent microbial shifts during crayfish decomposition in freshwater and sediment under different environmental conditions

Trastuzumab Deruxtecan Is Approved in EU for HER2-Low Metastatic Breast Cancer

The European Commission approval for trastuzumab deruxtecan in HER2-low metastatic breast cancer is based on data from the phase 3 DESTINY-Breast04 trial. Trastuzumab deruxtecan (Enhertu) was approved in the European Union for adult patients with metastatic HER2-low breast cancer following prior chemotherapy or disease recurrence within 6 months of receiving…

Continue Reading Trastuzumab Deruxtecan Is Approved in EU for HER2-Low Metastatic Breast Cancer

Inferring genetic structure when there is little: population genetics versus genomics of the threatened bat Miniopterus schreibersii across Europe

Charlesworth, B. & Charlesworth, D. Population genetics from 1966 to 2016. Heredity 118, 2–9 (2017). CAS  Google Scholar  Orsini, L., Vanoverbeke, J., Swillen, I., Mergeay, J. & Meester, L. Drivers of population genetic differentiation in the wild: Isolation by dispersal limitation, isolation by adaptation and isolation by colonization. Mol. Ecol….

Continue Reading Inferring genetic structure when there is little: population genetics versus genomics of the threatened bat Miniopterus schreibersii across Europe

Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study

Background Clinical trial data are scarce for the use of prophylaxis in people with non-severe haemophilia A. The HAVEN 6 study aims to assess safety and efficacy of emicizumab prophylaxis in people with non-severe haemophilia A without factor VIII (FVIII) inhibitors. Methods HAVEN 6 is a multicentre, open-label, single-arm, phase…

Continue Reading Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study

Qiagen Weighs Stake Sale in $1 Billion Bioinformatics Arm

(Bloomberg) — Qiagen NV is weighing the sale of a minority stake in its bioinformatics division, which could value that business at more than $1 billion, people familiar with the matter said.  The Dutch diagnostics firm is working with a financial adviser as it explores bringing in an investor, according…

Continue Reading Qiagen Weighs Stake Sale in $1 Billion Bioinformatics Arm

Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains

Faraone, S. V. et al. Attention-deficit/hyperactivity disorder. Nat. Rev. Dis. Prim. 1, 15020 (2015). Article  Google Scholar  Franke, B. et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol. Psychiatry 17, 960–987 (2012). Article  CAS  Google Scholar  Dalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H….

Continue Reading Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains

Global Protein Expression Systems Market, By Expression System

Global Protein Expression Systems Market The global protein expression systems market size was valued at US$ 1.2 billion in 2017, and is expected to witness a CAGR of 11.1% over the forecast period (2023 – 2032 In branches of science such as biochemistry, molecular biology, and protein research, which depend…

Continue Reading Global Protein Expression Systems Market, By Expression System

Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Sotyktu (deucravacitinib) for the treatment of adults with moderate-to-severe plaque psoriasis. Sotyktu, an oral medication taken once-daily, is a first-in-class, selective,…

Continue Reading Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

Sol-Gel Acquires Patidegib, a Phase 3,

Patidegib, an Orphan Drug candidate, broadens Sol-Gel’s pipeline with the potential to be the first therapy for preventing new basal cell carcinomas in Gorlin syndrome, if approved by the FDA Phase 3 study expected to initiate in the second half of 2023, with results expected by the end of 2025…

Continue Reading Sol-Gel Acquires Patidegib, a Phase 3,

NICE Backs Gilead Sciences’ Yescarta as Third-Line Option for Lymphoma Patients

NEW YORK – The UK’s National Institute for Health and Care Excellence on Thursday recommended that the National Health Service provide Gilead Sciences’ autologous CAR T-cell therapy Yescarta (axicabtagene ciloleucel) as a third-line option for patients in England with relapsed or refractory diffuse large B-cell lymphoma. Yescarta has been available…

Continue Reading NICE Backs Gilead Sciences’ Yescarta as Third-Line Option for Lymphoma Patients